BIOA vs ZTS · rev $9.0M vs P/E 25, rev $2.47B
BioAge Labs, Inc (BIOA) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
BIOA currently screens at market cap $697.9M. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the BIOA and ZTS stock pages for the full models.
Not investment advice.